Spots Global Cancer Trial Database for Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
Official Title: A Phase Two Study of ZD6474 in Patients With Relapsed Multiple Myeloma
Study ID: NCT00047788
Conditions
Study Description
Brief Summary: The primary objective is to assess the efficacy of ZD6474 when given orally to patients with relapsed multiple myeloma. A minimum of 15 and a maximum of 30 evaluable patients will be entered on study
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, New York, New York, United States
Research Site, Edmonton, Alberta, Canada
Research Site, Halifax, Nova Scotia, Canada
Research Site, Hamilton, Ontario, Canada
Research Site, London, Ontario, Canada
Research Site, Toronto, Ontario, Canada
Research Site, Montreal, Quebec, Canada
Contact Details
Name: Clinical Sciences & Operations
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
